← Back to Search

Motivational Network Intervention for Substance Abuse

Phase 1
Waitlist Available
Research Sponsored by RAND
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

This trial will test a computer program that uses motivational interviewing to help young adults recently transitioned to supportive housing to reduce substance use and increase positive social connections.

Eligible Conditions
  • Substance Abuse

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of days consumed 5 (for men) or 4 (for women) drinks on a single occasion
Number of days drug used
Number of drinking days
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
The intervention will consist of four sessions spaced two weeks apart that will last approximately 30 minutes each and consist of two parts: a network interview to capture network data about the time period since their last interview and a discussion of a resulting network visualization conducted in a motivational interviewing style. Participants will receive the intervention as part of existing case management.
Group II: Usual CareActive Control1 Intervention
As part of residency, participants receive regular case management meetings.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Motivational Network Intervention
2021
Completed Phase 1
~40

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

RANDLead Sponsor
138 Previous Clinical Trials
510,858 Total Patients Enrolled
5 Trials studying Substance Abuse
1,728 Patients Enrolled for Substance Abuse
National Institute on Drug Abuse (NIDA)NIH
2,492 Previous Clinical Trials
2,623,020 Total Patients Enrolled
153 Trials studying Substance Abuse
706,818 Patients Enrolled for Substance Abuse
~8 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top